Application of radiomics for diagnosis, subtyping, and prognostication of medulloblastomas: a systematic review.

IF 2.5 3区 医学 Q2 CLINICAL NEUROLOGY
Maryam Fotouhi, Ataollah Shahbandi, Fardin Samadi Khoshe Mehr, Mahdi Mohammadzadeh Shahla, Seyed Mobin Nouredini, Samuel B Kankam, MirHojjat Khorasanizadeh, Lola B Chambless
{"title":"Application of radiomics for diagnosis, subtyping, and prognostication of medulloblastomas: a systematic review.","authors":"Maryam Fotouhi, Ataollah Shahbandi, Fardin Samadi Khoshe Mehr, Mahdi Mohammadzadeh Shahla, Seyed Mobin Nouredini, Samuel B Kankam, MirHojjat Khorasanizadeh, Lola B Chambless","doi":"10.1007/s10143-024-03060-1","DOIUrl":null,"url":null,"abstract":"<p><p>Applications of radiomics for clinical management of medulloblastomas are expanding. This systematic review aims to aggregate and overview the current role of radiomics in the diagnosis, subtyping, and prognostication of medulloblastomas. The present systematic review was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. PubMed/MEDLINE were searched using a standardized search term. Articles found within the database from the inception until November 2022 were considered for screening. Retrieved records were screened independently by two authors based on their titles and abstracts. The full text of selected articles was reviewed to finalize the eligibility. Due to the heterogeneity of included studies, no formal data synthesis was conducted. Of the 249 screened citations, 21 studies were included and analyzed. Radiomics demonstrated promising performance for discriminating medulloblastomas from other posterior fossa tumors, particularly ependymomas and pilocytic astrocytomas. It was also efficacious in determining the subtype (i.e., WNT+, SHH+, group 3, and group 4) of medulloblastomas non-invasively. Regarding prognostication, radiomics exhibited some ability to predict overall survival and progression-free survival of patients with medulloblastomas. Our systematic review revealed that radiomics represents a promising tool for diagnosis and prognostication of medulloblastomas. Further prospective research measuring the clinical value of radiomics in this setting is warranted.</p>","PeriodicalId":19184,"journal":{"name":"Neurosurgical Review","volume":"47 1","pages":"827"},"PeriodicalIF":2.5000,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurosurgical Review","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10143-024-03060-1","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Applications of radiomics for clinical management of medulloblastomas are expanding. This systematic review aims to aggregate and overview the current role of radiomics in the diagnosis, subtyping, and prognostication of medulloblastomas. The present systematic review was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. PubMed/MEDLINE were searched using a standardized search term. Articles found within the database from the inception until November 2022 were considered for screening. Retrieved records were screened independently by two authors based on their titles and abstracts. The full text of selected articles was reviewed to finalize the eligibility. Due to the heterogeneity of included studies, no formal data synthesis was conducted. Of the 249 screened citations, 21 studies were included and analyzed. Radiomics demonstrated promising performance for discriminating medulloblastomas from other posterior fossa tumors, particularly ependymomas and pilocytic astrocytomas. It was also efficacious in determining the subtype (i.e., WNT+, SHH+, group 3, and group 4) of medulloblastomas non-invasively. Regarding prognostication, radiomics exhibited some ability to predict overall survival and progression-free survival of patients with medulloblastomas. Our systematic review revealed that radiomics represents a promising tool for diagnosis and prognostication of medulloblastomas. Further prospective research measuring the clinical value of radiomics in this setting is warranted.

将放射组学应用于髓母细胞瘤的诊断、亚型和预后:系统综述。
放射组学在髓母细胞瘤临床治疗中的应用正在不断扩大。本系统综述旨在汇总和概述放射组学目前在髓母细胞瘤的诊断、亚型和预后中的作用。本系统综述根据系统综述和荟萃分析首选报告项目(PRISMA)指南进行。使用标准检索词对 PubMed/MEDLINE 进行了检索。在数据库中找到的从开始到 2022 年 11 月的文章都在筛选之列。检索到的记录由两位作者根据标题和摘要进行独立筛选。对所选文章的全文进行审阅,以最终确定是否符合条件。由于纳入的研究存在异质性,因此没有进行正式的数据综合。在筛选出的 249 篇引文中,有 21 项研究被纳入并进行了分析。放射组学在鉴别髓母细胞瘤与其他后窝肿瘤(尤其是外胚瘤和柔毛细胞星形细胞瘤)方面表现良好。此外,它还能无创判断髓母细胞瘤的亚型(即 WNT+、SHH+、第 3 组和第 4 组)。在预后方面,放射组学在预测髓母细胞瘤患者的总生存期和无进展生存期方面表现出一定的能力。我们的系统综述显示,放射组学是诊断髓母细胞瘤和预后的一种有前途的工具。有必要进一步开展前瞻性研究,衡量放射组学在这种情况下的临床价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Neurosurgical Review
Neurosurgical Review 医学-临床神经学
CiteScore
5.60
自引率
7.10%
发文量
191
审稿时长
6-12 weeks
期刊介绍: The goal of Neurosurgical Review is to provide a forum for comprehensive reviews on current issues in neurosurgery. Each issue contains up to three reviews, reflecting all important aspects of one topic (a disease or a surgical approach). Comments by a panel of experts within the same issue complete the topic. By providing comprehensive coverage of one topic per issue, Neurosurgical Review combines the topicality of professional journals with the indepth treatment of a monograph. Original papers of high quality are also welcome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信